» Articles » PMID: 12605375

Distribution of P53 Alterations in a Case of Gliomatosis Cerebri

Overview
Journal Hum Pathol
Specialty Pathology
Date 2003 Feb 28
PMID 12605375
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Gliomatosis cerebri (GC) is a rare neuroepithelial tumor characterized by diffuse infiltration of large parts of the brain. The origin of GC is unknown, and the molecular alterations underlying this tumor have not been determined. Because mutations in the p53 tumor-suppressor gene are frequent in common gliomas, we investigated the distribution of p53 alterations by immunohistochemistry and direct sequencing in a GC case with a disease involving both hemispheres and the basal ganglia. Nuclear accumulation of p53 protein was detected in a single region with features of a high-grade glioma. In the remaining 10 regions, corresponding to low-grade gliomas, no p53 accumulation was seen. In 1 low-grade tumor sample, a pathogenic splice site mutation was detected. These findings suggest that p53 alterations occur in GC, but are no prerequisite of malignant progression. The distribution of p53 alterations demonstrates the existence of topographically different clones in 1 patient.

Citing Articles

Gliomatosis cerebri type 1 with extensive involvement of the spinal cord and BRAF V600E mutation.

Fernandez-Vega I, Quirk J, Norwood F, Sibtain N, Laxton R, Bodi I Pathol Oncol Res. 2013; 20(1):215-20.

PMID: 24353007 DOI: 10.1007/s12253-013-9732-z.


Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event.

Lass U, Numann A, von Eckardstein K, Kiwit J, Stockhammer F, Horaczek J PLoS One. 2012; 7(7):e41298.

PMID: 22844452 PMC: 3402513. DOI: 10.1371/journal.pone.0041298.


Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri.

Min H, Kim B, Park S J Neurooncol. 2008; 90(3):259-66.

PMID: 18704270 DOI: 10.1007/s11060-008-9665-7.


Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.

Braeuninger S, Schneider-Stock R, Kirches E, Powers J, Korones D, Mawrin C J Neurooncol. 2006; 82(1):23-7.

PMID: 16955219 DOI: 10.1007/s11060-006-9245-7.


Assessment of tumor cell invasion factors in gliomatosis cerebri.

Mawrin C, Schneider T, Firsching R, Wiedemann F, Dietzmann K, Bornemann A J Neurooncol. 2005; 73(2):109-15.

PMID: 15981099 DOI: 10.1007/s11060-004-4206-5.